---

$1.81

+0.0300 ( +1.69% ) 610.9K

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

Open	$1.81
Previous Close	$1.78
Volume	610.9K
Market Cap	$75.72M
Day Range	$1.79 - $1.90
52 Week Range	$1.54 - $5.50
Shares Outstanding	42.54M
Change %	+1.69%
Net Change	▲ 0.0300
Insider Ownership	N/A
Exchange	NYSE
Sector	Healthcare
Industry	Biotech
IPO Year	2020
Country
Underwriter	IPO Intelligence Only

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2023-11-21	Sale	-41186.00	Maccecchini Maria-Luisa
2023-11-21	Sale	-824.00	Hagopian Henry III
2023-11-21	Sale	-1000.00	Bruck Claudine